Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1
- 1 December 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 110 (1-2) , 193-200
- https://doi.org/10.1016/s0304-3835(96)04502-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cyclins and cyclin-dependent kinases: a biochemical viewBiochemical Journal, 1995
- Cytotoxicities of ginseng saponins and their degradation products against some cancer cell linesArchives of Pharmacal Research, 1995
- Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycleBioEssays, 1995
- Principles of CDK regulationNature, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Mammalian G1 cyclinsCell, 1993
- Association of human cyclin E with a periodic G1-S phase protein kinaseScience, 1992
- Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell CycleScience, 1992
- Mechanism of Action of Ginsenoside Rh2: Uptake and Metabolism of Ginsenoside Rh2 by Cultured B16 Melanoma CellsJournal of Pharmaceutical Sciences, 1991
- Chemical Studies on Crude Drug Precession. I. On the Constituents of Ginseng Radix Rubra (1)YAKUGAKU ZASSHI, 1983